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WS18.1 Evolution of pregnancies in the French CF Registry:
1992–2011
L. Lemonnier1, M.-H. Cazes2, G. Bellis2, M. Sponga1, I. Durieu3. 1Vaincre la
Mucoviscidose, Paris, France; 2Institut National Etudes Demographiques, Paris,
France; 3Hospices Civil de Lyon, Universite´ de Lyon, Paris, France
More women with CF now become pregnant. Clinicians and patients have many
questions about the evolution and prognosis of these pregnancies.
Aim: To describe evolution of pregnancies and clinical status of pregnant women
in the French CF Registry.
Methods: Data collected between 1992 and 2011 from women aged 15−49
registered in the Registry were used. For some incomplete data, only follow-up
data collected between 2002 and 2011 were analyzed.
Results: During those 20 years, 322 women became pregnant, for a total of 394
pregnancies (average number of pregnancies per woman: 1.2). The annual number of
cases has increased (8 in 1992 to 48 in 2011). Age at ﬁrst pregnancy remains steady
(mean±SD: 26.8±5.4 years). Mean VEMS was 51.6% in 1992 and 71.1% in 2011
and is concordant with evolution of VEMS in CF adult women. BMI collected the
year preceding pregnancy is constant over the period (mean±SD: 20.4±3). Between
2002 and 2011, the early pregnancy rate was 24.7‰; 72.5% of the women were PI
and 22% had diabetes. In total, 35 deaths were registered, occurring 5±3.8 years
after pregnancy on average. Mean age at death (31.4±8.3 years) exceeds that
of the CF population as a whole (29 years in 2010). Interestingly, 24 women
became pregnant after transplant (mean time to pregnancy after transplantation:
3.9±2.3 years).
Conclusion: The annual number of pregnancies has increased dramatically over the
last 20 years. The clinical status of pregnant women evolves in a similar manner
to that of other adult women in the Registry. This work highlights the increasing
number of pregnancies in transplanted patients and it will be interesting to study
this speciﬁc population.
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Background: Improvements in health and survival of patients with CF have led to
many women having successful pregnancies.
Objectives: To assess the effects of pregnancy on nutritional and clinical indices
in women with CF.
Methods: Retrospective cohort study. Pre- and post-pregnancy (1year) data was
analysed in women with CF who had a pregnancy between 2008–2011 at The
Alfred, Melbourne. Variables studied included lung function, weight, BMI, HbA1c,
vitamin levels, duration of pregnancy and birth weight.
Results: All pregnancies resulted in live births (mean gestation period 37wks; mean
birth weight 2.8 kg). A total of 9 women (16−42 yrs, baseline FEV1 78%, BMI
21.5 kg/m2; 9 singleton pregnancies) were studied. Five women were pancreatic
insufﬁcient (PI), 2 had CFRDM. An average decline in FEV1 of 12% was observed
post-pregnancy. PI patients’ lung function decline was greater compared to PS
patients (−17.4% vs −4.7%, p= 0.32). Women with a FEV1 >60% gained more
weight than those with FEV1 <60% (11.5 kg vs 4.8 kg, p= 0.098); PS women gained
4.5 kg more during pregnancy than PI women. Women with PI had signiﬁcantly
lower Vitamin E (19.7mmol/l vs 25.3mmol/l, p= 0.015), lower Vitamin A and D
levels and bone density both pre- and post-pregnancy. HbA1c signiﬁcantly increased
post-pregnancy (5.63% vs 6%, p= 0.05). Three women (PI) developed gestational
diabetes (GDM), 1 developed CFRDM. All women are alive to date.
Conclusion: Pregnancy for women with CF is possible but can be associated with
speciﬁc adverse outcomes. Women with pre-existing poor lung function and PI
should be counselled antenatally to ensure adequate nutrition for optimal weight
gain and preservation of lung function.
WS18.3 Pregnancy outcomes in cystic ﬁbrosis: A 10-year experience
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Objectives: Whilst pregnancy can be well tolerated in CF, the additional physi-
ological demands may increase health risk for the mother and her baby. Current
understanding is limited by a paucity of published series. Our retrospective study
investigates pregnancy-related changes in CF.
Methods: A clinical database search enabled identiﬁcation of all pregnancies
at a tertiary unit during 2002–2012. Demographics considered were age, BMI,
pancreatic insufﬁciency, CF-related diabetes CFRD, pseudomonas colonization,
FEV1 and FVC. Longitudinal parameters included gestational age, gestational
diabetes, haemoptysis, and spirometry at delivery, 6 and 12 months postpartum.
Results: Nine pregnancies in 7 women were identiﬁed, comprising 5 vaginal
deliveries, 3 C-sections and 1 therapeutic termination.
• Age at conception was 28.7±7.7 years and BMI 23.1±4.3 kg/m2. 6/9 women
were pancreatic insufﬁcient, 2/9 had CFRD, and 8/9 were pseudomonas colo-
nized.
• 3/9 had preterm births (<37wks), 1/9 developed gestational diabetes, and signif-
icant haemoptysis occurred in 5/9.
• Spirometry results are summarised in Table 1.
Table 1. Peripartum lung function in CF (Mean±SD)
Lung function
Baseline Postpartum % reductions
Delivery 6 months 12 months
FEV % predicted 68.9±17.0 3.6±12.8 2.8±9.0 3.5±6.2
FVC % predicted 84.1±21.0 4.7±10.5 0.6±11.3 −3.2±12.7
FEV/FVC % predicted 76.8±7.6 5.9±8.1 5.4±7.3 −0.5±10.0
Conclusion: We observed modest falls in FEV1 immediately post-partum which
persisted at 12 months. Signiﬁcant haemoptysis occurred in more than half of
pregnancies; this complication has not previously been reported but warrants further
investigation.
WS18.4 Does the presence of diabetes affect lung function outcomes
in a pregnant individual with cystic ﬁbrosis?
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Objectives: To explore the differences in FEV1 during pregnancy in women with
cystic ﬁbrosis (CF) with and without diabetes.
Methods: Approximately 1100 individuals with CF have attended The Alfred CF
service since 1974. A retrospective cohort analysis was conducted revealing 55
children from 39 CF mothers. From these, 24 complete sets of maternal lung
function data were identiﬁed. Five of which have CF related diabetes (CFRD)
leading up to pregnancy, or developed Gestational Diabetes Mellitus (GDM) during
pregnancy. Mean age was 31 (18−42 years). Lung function data was obtained
12 months prior to pregnancy until 12 months post-delivery. Comparisons were
made between the average rate of decline in the year leading up to pregnancy, with
the 12 months post-delivery. Statistical analysis revealed signiﬁcant differences in
rates of decline leading up to pregnancy. Women with no known diabetes had a
rate of decline of 3.88% predicted per year (pred/yr). Women with diabetes had a
6.37% pred/yr rate of decline. Mean = 4.38% pred/yr. Current data in our service
suggests an annual rate of decline of 1.3% pred/yr. Minimal change was seen
between the two data points in the ‘no diabetes group’ (pre = 3.88%pred/FEV1/yr,
post = 4.4% pred/FEV1/yr). Where as the diabetes affected cohort continued to
decline at a greater rate than pre conception (pre = 6.37%pred/FEV1/yr, post =
13.1% pred/FEV1/yr).
Conclusion: A diagnosis of CFRD pre pregnancy is associated with an accelerated
rate of decline of lung function. Analysis of this data would suggest that the added
stress of pregnancy has a persistant impact on rate of decline.
